Description: The Coagulation Consult by Alan Lichtin, John Bartholomew An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP).The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the fields most recent developments. FORMAT Paperback LANGUAGE English CONDITION Brand New Publisher Description There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrands disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP).The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the fields most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with coagulation consult students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology. Back Cover There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrands disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the fields most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with a coagulation consult, students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology. Author Biography Alan Lichtin, MD, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, USAJohn Bartholomew, MD, Department of Cardiovascular Medicine and Hematology, Cleveland Clinic, Cleveland, OH, USA Table of Contents Laboratory Analysis of Coagulation.- Easy Bruisability.- Prolonged PT.- Prolonged PTT.- Prolongation of Both PT and aPTT.- Excessive Bleeding with Normal Prothrombin Time, Partial Thromboplastin Time, and Platelet Count.- Diagnosing Thrombocytopenia in the Clinic.- Thrombocytopenia in the Intensive Care Unit and after Solid Organ Transplantation.- Thrombocytosis.- Prolonged Bleeding after Surgery.- The Excessively Clotting Cancer Patient.- Thrombotic Risk factors.- Clotting around Catheters and Other Devices.- Heparin-Induced Thrombocytopenia.- Surgery on Patients on Antiplatelet Agents.- Newer Oral Anticoagulants.- Pregnancy. Review From the reviews:"The purpose is to address and bridge the gap in commonly encountered coagulation issues, today curiously artificially separated and managed by either vascular surgeons (thrombotic disorders) or clinical hematologists (bleeding disorders). … It also would be useful to anyone in training or in practice in any medical specialty involved in the long-term management of patients with these conditions. … a practical and very useful guide for clinical coagulation consultation, and a must if this is part of your clinical responsibilities." (Valerie L. Ng, Doodys Book Reviews, May, 2014) Long Description There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand s disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field s most recent developments. This case-directed book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted withcoagulation consult students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology. " Review Quote From the reviews: The purpose is to address and bridge the gap in commonly encountered coagulation issues, today curiously artificially separated and managed by either vascular surgeons (thrombotic disorders) or clinical hematologists (bleeding disorders). It also would be useful to anyone in training or in practice in any medical specialty involved in the long-term management of patients with these conditions. a practical and very useful guide for clinical coagulation consultation, and a must if this is part of your clinical responsibilities. (Valerie L. Ng, Doody s Book Reviews, May, 2014)" Feature Focuses on some of the newest areas of coagulation science and pharmacology, including recently approved medications such as dabigatran and rivaroxaban Includes chapters on post-surgical bleeding useful to surgeons, gynecologists, and intensivists Accessible case-directed approach offers practical advice and teaching points Details ISBN1493945017 Year 2016 ISBN-10 1493945017 ISBN-13 9781493945016 Format Paperback Language English Media Book DEWEY 616.157 Imprint Springer-Verlag New York Inc. Subtitle A Case-Based Guide Place of Publication New York Country of Publication United States Edited by John Bartholomew Pages 279 Short Title The Coagulation Consult AU Release Date 2016-08-23 NZ Release Date 2016-08-23 US Release Date 2016-08-23 UK Release Date 2016-08-23 Author John Bartholomew Birth 1948 Affiliation Rutgers University USA Position Graduate Student Qualifications J.D. Publisher Springer-Verlag New York Inc. Edition Description Softcover reprint of the original 1st ed. 2014 Publication Date 2016-08-23 Alternative 9781461495598 Audience Professional & Vocational Illustrations 38 Illustrations, color; 8 Illustrations, black and white; XII, 279 p. 46 illus., 38 illus. in color. We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! TheNile_Item_ID:100253430;
Price: 291.16 AUD
Location: Melbourne
End Time: 2025-01-13T18:48:43.000Z
Shipping Cost: 70.7 AUD
Product Images
Item Specifics
Restocking fee: No
Return shipping will be paid by: Buyer
Returns Accepted: Returns Accepted
Item must be returned within: 30 Days
ISBN-13: 9781493945016
Book Title: The Coagulation Consult
Item Height: 254 mm
Item Width: 178 mm
Author: Alan Lichtin, John Bartholomew
Publication Name: The Coagulation Consult: a Case-Based Guide
Format: Paperback
Language: English
Publisher: Springer-Verlag New York Inc.
Subject: Medicine, Biology
Publication Year: 2016
Type: Textbook
Item Weight: 5525 g
Number of Pages: 279 Pages
